Clinical trial
Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)
NCT00396110 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00396110 |
|---|---|
| Title | Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET) |
| Official title | Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET) |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hypercholesterolemia, Coronary Heart Disease |
| Enrollment | 3,889 |
| Start date | Feb 1, 2003 |
| First posted | Nov 6, 2006 |
| Last update posted | Nov 6, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: